首页> 外文期刊>European Heart Journal - Case Reports >Case report of simultaneous transcatheter mitral valve-in-valve implantation and percutaneous closure of two paravalvular leaks
【24h】

Case report of simultaneous transcatheter mitral valve-in-valve implantation and percutaneous closure of two paravalvular leaks

机译:同时转截管二尖瓣瓣膜内植入和两种静脉泄漏的经皮闭闭报告

获取原文
           

摘要

Background Concomitant structural degeneration of surgical mitral bioprostheses and paravalvular leak (PVL) is rare but potentially fatal. Data pertaining to simultaneous transcatheter mitral valve implantation (TMVI) and percutaneous PVL closure are limited, and the optimal treatment strategy remains undetermined. We report a case of simultaneous TMVI and double percutaneous PVL closure in a patient with a degenerated bioprosthetic mitral valve and associated medial and lateral PVLs. Case summary A 75-year-old woman who underwent combined aortic (Edwards Perimount Magna 19?mm) and mitral (Edwards Perimount Magna 25?mm) surgical valve replacement 6?years ago was referred for treatment of new-onset orthopnoea and severely reduced exercise capacity. Transoesophageal echocardiography revealed severe mitral stenosis and concomitant moderate to severe mitral regurgitation, originating from two PVLs located medial and lateral from the surgical bioprosthesis. Due to high surgical risk, we performed successful transseptal mitral valve-in-valve (ViV) implantation combined with the closure of two PVLs during the same procedure. Discussion Although surgery should be considered as a first-line treatment in this setting, most patients have extremely high or prohibitive surgical risk inherent to repeat open heart surgery. Mitral ViV implantation appears a reasonable treatment option for patients with failed mitral bioprostheses. Furthermore, a recent study of percutaneous PVL closure showed no significant difference in long-term all-cause mortality compared with redo open-heart surgery. Simultaneous TMVI and percutaneous PVL closure appears feasible in selected high-risk patients. Mitral regurgitation , Paravalvular leak , Transcatheter mitral valve implantation , Percutaneous paravalvular leak closure , Case report Learning points Simultaneous transcatheter mitral valve implantation (TMVI) and percutaneous paravalvular leak (PVL) closure can be an option in patients with high surgical risk. Pre-procedural planning by multimodality imaging is crucial for a safe intervention when performing combined TMVI and percutaneous PVL.
机译:背景技术外科二萜生物制剂和静脉曲张(PVL)的结构退化是罕见的但可能致命的。与同时经截面二尖瓣瓣膜注入(TMVI)和经皮PVL闭合有关的数据是有限的,并且最佳处理策略仍未确定。我们在具有退化的生物假体二尖瓣和相关的内侧和横向PVL的患者中报告了同时TMVI和双经皮PVL闭合的情况。案例摘要一名75岁的女性接受主动脉(Edwards Perimount Magna 19?MM)和二尖瓣(Edwards Perimount Magna 25?MM)手术瓣膜更换6?几年前被提及治疗新出售正交肉,并且严重减少运动能力。转铁脑超声心动图揭示了严重的二尖瓣狭窄和伴随着严重二尖瓣的反流,来自于外科生物假体的内侧和横向的两个PVL。由于手术风险高,我们在相同的过程中执行了成功的纵向二尖瓣内阀(VIV)植入与两个PVL的闭合结合。讨论虽然手术应该被视为这种环境中的一线治疗,但大多数患者具有极高或令人望远的手术风险固有,以重复开放的心脏手术。二尖瓣VIV植入似乎有患者失败的二尖症生物制剂患者的治疗选择。此外,与重做露天手术相比,近期对经皮PVL闭合的研究表明,长期全导致死亡率没有显着差异。同时TMVI和经皮PVL闭合在选定的高风险患者中出现可行。二尖瓣流动,瓣膜泄漏,转椎间泄漏,经皮静脉泄漏闭合,案例报告学习点同时转截管二尖瓣植入(TMVI)和经皮静脉泄漏(PVL)闭合可以是具有高手术风险的患者的选择。通过多模成像进行预过程规划对于执行组合TMVI和经皮PVL时的安全干预是至关重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号